No Data
No Data
Chordia Therapeutics: Correction confirmation
Volume change rate ranking (1 PM) ~ Ashiro, Sanbio, ETC are ranked.
In the volume change rate ranking, by comparing the average volume over the last five days with the volume on the day of reporting, one can understand the trends in stock selection and the interests of market participants. ■ Top volume change rates [As of December 17, 13:32] (Comparison of average volume over the last five days) Code ⇒ Stock ⇒ Volume ⇒ 5-Day Average Volume ⇒ Volume Change Rate ⇒ Stock Price Change Rate <7378> Asiro 1539000122872.93 17.99% 0.1379% <6836> Platform 29190061
Chordia Therapeutics Unveils New Research Insights
Company Research Report: Chordia Therapeutics Inc. (190A)
Chordia Therapeutics
■ Chordia Therapeutics <190A> Estimated number of shares to be released: 600,000 shares (estimated) Release date: 2024/12/11 Target holders: Estimated shares Daisuke Morishita: 600,000 shares *Based on the prospectus.
Chordia Therapeutics: Extraordinary Report